Temporarily Closed. New orders are paused while we resolve an unforeseen operational issue. Existing orders will still be fulfilled.

BPC-157 + TB-500

Accelerating

bpc-157-tb-500 appears in 1,415 indexed publications going back to 1982, including 70 in the past twelve months. 19 registered trials appear on ClinicalTrials.gov.

1,415
Indexed publications
70
Past 12 months, against 36 the year before
19
Registered clinical trials
15,038
Monthly readers on Wikipedia, down 33%

On This Figure
BPC-157 + TB-500 is a blend. These figures combine its components (BPC-157, TB-500), so totals are an upper bound where a single paper covers more than one of them.

Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
20155
20168
201711
20189
20196
202011
202119
202212
202310
20245
202519
202631
Public Attention

Who is looking it up

Monthly readers of the BPC-157 + TB-500 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-092026-08
Clinical Trials

The registered pipeline

Early Phase 1
0
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0

Phase distribution across the most recently updated registered trials.

References

Most recent work

The newest indexed records mentioning BPC-157 + TB-500, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

  1. 2026-08-29·Applied biochemistry and biotechnology

    Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis

    Zhang H, Shao L, Feng Q et al.

  2. 2026-08-24·Current pain and headache reports

    Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management

    Luansritisakul C, Chiang MC, Burns SL et al.

  3. 2026-08-17·Molecular biomedicine

    Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling

    Zhao TR, Hu EB, Wang MW et al.

  4. 2026-08-11·The American journal of sports medicine

    Peptide Supplements and Their Therapeutic Applications in Sports Medicine

    Tewari K, Liu TP, Im C et al.

  5. 2026-08-01·Clinical science (London, England : 1979)

    Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway

    Ouyang X, Long Z, Xu X et al.

  6. 2026-07-27·The Analyst

    Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices

    Mazzarino M, Colpaert T, Deventer K et al.

  7. 2026-07-23·Joint diseases and related surgery

    Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study

    Biçer O, Adanir O, Güleryüz Y et al.

  8. 2026-07-10·Experimental eye research

    Understanding the effects of ciprofloxacin on corneal epithelial cells: a study using electric cell-substrate impedance sensing (ECIS) technology

    Banga L, Shawky M, Ebrahim F et al.

In the Catalogue

BPC-157 + TB-500 available from Polaris Research

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-09-13.